http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-405276-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd617dc43a4c986d2dd81e4cb39d9dd |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D231-20 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D231-20 |
filingDate | 1972-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 1975-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-405276-A1 |
titleOfInvention | A PROCEDURE TO PRODUCE 1- (4-METHYL-6-HYDROXY-2-PIRI-MIDINYL) -3-METHYL-PIRAZOLINE-5-ONA. |
abstract | A intermediate, 1-(4-methyl-6-hydroxy-2-pyrimidinyl)-3-methylpyrazoline-5-one, is produced by reacting aminoguanidine or one of its salts with acetoacetamide, and then reacting the product with an alkyl acetoacetate in the presence of a basic catalyst. The intermediate is useful for producing 1-(4-methyl-6-methoxy-2-pyrimidinyl)-3-methyl-5-methoxypyrazole which has been employed clinically as an excellent anti-inflammatory drug. |
priorityDate | 1971-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.